Kumamaru Hirotani, the vice director of Aoi Hospital in Kawasaki, stated that nicotine replacement therapy (NRT), such as nicotine patches, did not produce the expected results. However, since the introduction of heated tobacco products (HTP) locally, smoking rates have significantly decreased.
In summary, they did not see great success with nicotine replacement therapies. However, since 2014, three heated tobacco products have been officially introduced nationwide in Japan and have penetrated 25% of the total smoking population. As a result, the smoking rate in Japan has successfully decreased over the past three to four years, according to Hiroya in a recent online seminar.
Research Shows That Heating Tobacco Products Decreases Cigarette Sales by 34%
Frost & Sullivan recently collaborated with tobacco company Philip Morris International (PMI) to publish a paper titled "Reducing Tobacco Harms and Novel Nicotine and Tobacco Products: Evidence from the Japanese Market". The paper reflects their argument that the introduction of HTP has led to a 34% decrease in cigarette sales.
The commercial viability of Japanese HTP is strongly linked to the significant decline in traditional cigarette sales, surpassing previous rates of decline. Furthermore, even with the introduction of heated tobacco products, all tobacco products (both heated tobacco and traditional cigarettes) continue to experience a decrease in sales. While evidence is mixed, data from the 2019 National Health Survey suggests that 76% of consumers only use heated tobacco products, with only 24% of HTP users maintaining dual use," stated Mark Dougan, Healthcare Consulting Director at Frost & Sullivan.
According to him, the Japanese government distinguishes HTP from traditional cigarettes in terms of tax, health warnings, and indoor usage restrictions, and the regulatory framework for heated tobacco products is usually more lenient than for traditional cigarettes.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the viewpoint of 2FIRSTS and 2FIRSTS is unable to confirm the authenticity or accuracy of the contents of the article. The compilation of this article is solely intended for industry exchange and research.
Due to limitations in the compiling ability, the translated article may not fully express the original text. Please refer to the original text for accuracy.
2FIRSTS remains completely aligned with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or international statements and positions.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
